Stocktoria
HERON THERAPEUTICS, INC. /DE/ HRTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1987-08-26
HERON THERAPEUTICS, INC. /DE/ statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 73.3% | 73.2% | 48.8% | 49.0% | — |
| Operating margin | -1.6% | -8.0% | -87.1% | -162.2% | -252.3% |
| Net margin | -13.0% | -9.4% | -87.0% | -169.1% | -255.6% |
| FCF margin | -18.0% | -16.8% | -47.5% | -138.1% | -239.0% |
| Return on assets | -7.9% | -5.8% | -49.7% | -72.5% | -72.2% |
| Return on equity | -140.9% | 40.4% | 325.4% | -1341.2% | -284.5% |
| Current ratio | 2.48 | 2.29 | 2.37 | 2.49 | 3.58 |
| Revenue growth | 7.4% | 13.6% | 18.0% | 24.7% | -2.6% |
Source: SEC EDGAR filings · CIK 0000818033 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.